58
Participants
Start Date
October 31, 2010
Primary Completion Date
March 24, 2017
Study Completion Date
March 24, 2017
panitumumab, mytomicin C, 5-FU, radiation
"Radiation therapy will be administered concurrent with chemotherapy and Panitumumab treatment. It will start the day 1 of the systemic treatment. That is, the first day of radiation therapy will be the day of the administration of the first dose of Panitumumab and Mitomycin C, as well as the first day of the first 96-hours course of 5-FU continuous infusion. On day 1, drugs and radiation will be administered in the following order:~* First, Panitumumab. Panitumumab will be administered by IV infusion on day 1, and every 2 weeks during 8 weeks~* Then Mitomycin C, 10mg/m2 on days 1 and 29~* Then start the 5-FU continuous infusion, 1000mg/m2 on days 1-4 and 29-32~* Finally, no less than 2 hours after the start of the 5-FU infusion, first dose of radiation therapy."
Centro Oncológico de Galicia, A Coruña
Hospital Virgen Blanca, León
Hospital Universitario La Princesa, Madrid
Hospital Universitario Gregorio Marañón, Madrid
Fundación Jiménez Díaz, Madrid
Hospital Universitario La Paz, Madrid
Hospital Infanta Sofía, San Sebastián de los Reyes
Hospital Virgen de la Victoria, Málaga
Hospital Universitario de Salamanca, Salamanca
Hospital Universitario Marqués de Valdecilla, Santander
Hospital Universitario Virgen del Rocío, Seville
Instituto Valenciano de Oncología, Valencia
Hospital General de Valencia, Valencia
Hospital Universitario Miguel Servet, Zaragoza
Hospital Universitario Germans Trias i Pujol. Institut Català Oncologia, Badalona
Corporació Sanitaria Parc Taulí, Sabadell
Hospital del Mar, Barcelona
Hospital Universitario Vall Hebron, Barcelona
Hospital Clínic i Provincial, Barcelona
Hospital Santa Creu i Sant Pau, Barcelona
Collaborators (1)
Amgen
INDUSTRY
Trial Form Support S.L.
OTHER
Grupo Espanol Multidisciplinario del Cancer Digestivo
OTHER